Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders for Inhibrx Biosciences, Inc., held on June 3, 2026. The meeting was conducted virtually to address corporate governance matters, including the election of directors and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the results of stockholder votes and does not contain financial performance data.
Material Changes and Voting Results
A quorum was established with 11,541,232 shares present, representing approximately 79% of the 14,607,286 shares entitled to vote. The following actions were taken:
- Proposal 1 (Election of Directors): Two Class II directors were elected to serve until the 2029 Annual Meeting.
- Douglas G. Forsyth: 7,608,469 votes For; 1,463,474 votes Withheld; 2,469,289 Broker Non-Votes.
- Kimberly Manhard: 9,035,097 votes For; 36,846 votes Withheld; 2,469,289 Broker Non-Votes.
- Proposal 2 (Ratification of Auditor): The appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
- Votes: 11,510,478 For; 30,347 Against; 407 Abstained.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. Detailed descriptions of the matters voted upon are referenced as being available in the definitive proxy statement filed on April 23, 2026.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 23, 2026, for detailed biographies of the elected directors and the rationale for the auditor appointment.
- Confirm the total number of shares outstanding and the record date (April 7, 2026) to validate the quorum calculation.
- Review the Company's upcoming 10-K or 10-Q filings for the fiscal year ending December 31, 2026, to obtain financial metrics absent from this 8-K.